The University of Massachusetts Amherst
University of Massachusetts Amherst

Search Google Appliance


Edward Price ('90) to speak with Undergraduate ChemEng Majors

(Pizza available)


Friday, September 30, 2016 - 12:00pm


LGRT 123

Relevant Majors: 

Chemical Engineering


Thinking of your Future?
? Hungry ?

Come to a talk/discussion with an alumnus
about preparing for industry and/or graduate school
and entrepreneurship (plus…pizza)


Edward Price, (’90)
President and CEO, PCI Synthesis

Noon on Friday, Sept. 30th in LGRT 123

(small discussion to follow at 1:00 in Goessmann 261)

Price is president and CEO of PCI Synthesis (, a pharmaceutical development Contract Manufacturing Organization (CMO) based in Newburyport, Mass., which is the largest small-molecule drug-substance manufacturer in New England. PCI is a clinical and commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products.

With more than 25 years of experience in chemical operations and engineering manufacturing, Price has grown PCI from a basic chemical manufacturer into the leading CMO that it is today. With a robust product pipeline, PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules and APIs used in a variety of pharmaceutical products. Over the last three years PCI has been awarded a total of eight individual CMO awards by Life Science Leader magazine. The eight individual awards PCI received covered all five award categories, making PCI the most awarded drug substance CMO in North America.

As an industry thought-leader, Price also serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass Amherst. Price is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturers and Affiliates (SOCMA). Numerous publications have written about PCI Synthesis, most recently in Pharmaceutical ProcessingPharmaceutical OutsourcingManufacturing ChemistPharmaceutical Compliance MonitorContract Pharma, the Boston Business JournalMass High Tech,Chemical & Engineering News, and BioSpace.

Prior to founding the company, Price served in numerous positions at several leading custom chemical manufacturers, including ChemDesign and PolyOrganix (previously Borregaard Synthesis). He holds a BS in chemical engineering from UMass Amherst and completed graduate studies in chemical engineering at Texas A&M University.


Follow UMass Chemical Engineering: